• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
  • Contact Us
WeedWeek

WeedWeek

WeedWeek is the best way to keep up with the green rush

  • Membership
  • My Account
  • LinkedIn
  • Instagram
  • Twitter
  • Politics
  • Money
  • Ops
  • Brands
  • Culture
  • Events
Sponsored

The Promise of Ketamine as a Rapid-Acting Antidepressant

Depression is a mental health condition that affects millions of individuals worldwide. Ketamine is a medication that has been used for decades as an anesthetic agent, but new research is unveiling its potential as a rapid-acting antidepressant.

Sponsored Post
By Alex Halperin
04/22/2023 07:00 AM GMT-0700
FacebookTweetPin

Lutz, Florida USA (Newsworthy.ai) Saturday Apr 22, 2023 @ 7:00 AM Pacific —

Ketamine is a medication that has been used for decades as an anesthetic agent, but new research is unveiling its potential as a rapid-acting antidepressant.

Depression is a mental health condition that affects millions of individuals worldwide. The current medications used to treat it, such as SSRIs, can take weeks or months before patients start seeing any benefits. However, research into the potential of Ketamine as a rapid-acting antidepressant is pointing to very promising results.

[gravityform id="5" title="true" description="false" ajax="true" tabindex=""]

According to recent studies, the administration of low doses of Ketamine intravenously has been shown to relieve depressive symptoms within hours of being given to patients. More encouragingly, remission of symptoms may last up to one week, giving doctors and researchers additional time to develop long-term treatment plans alongside traditional therapies.

While more research and clinical trials are needed, the results obtained until now show that Ketamine could be a highly beneficial treatment for the millions of individuals currently suffering from depression. These findings could represent a major turning point in how doctors and researchers approach the treatment of depression.

Related

lawmakers
Gavin Newsom

Newsbrief: Newsom’s MED bill veto sparks anger

The rapid-acting nature of Ketamine could make a tremendous impact on the lives of people suffering from depression.

The promising results of Ketamine for the treatment of depression have opened the door for further research and clinical trials. If successful, Ketamine could be a revolutionary treatment for depression and offer new hope for the millions of people affected by this condition.

About Turning Point Wellness Center

Turning Point Wellness Center is dedicated to providing innovative and effective solutions to help patients improve their mental and physical well-being. At Turning Point, we specialize in providing Ketamine treatments as an alternative to traditional psychiatric medications. We believe that patients deserve to have access to safe and effective treatments without the negative side effects associated with prescription drugs. In addition to Ketamine, we also offer hydration and nutrient IV therapy.


This press release is distributed by the Newsworthy.ai™ Press Release Newswire – News at the speed of influence™. Reference URL for this press release is here.

Share:
FacebookTweetPin
Filed Under:
Medical Marijuana

Primary Sidebar

Recent Webinar

Growth in a Tight Market

WeedWeek Wonks: Growth in a Tight Market

Duration 60 minutes
Speakers Leah Heise, Alex Halperin

RSVP

Join WeedWeek California Pro Today!

WeedWeek Pro is the essential news and information resource for California cannabis professionals.

  • Access the Weedweek California Pro Newsletter
  • Access the California Tax and License Maps
  • Steep discounts on job posts in the WeedWeek career center
Sign Up

Get a risk-free 14 day trial for FREE!

Most Read

  • Regulation & Compliance

    EXCLUSIVE: We tested top Calif. prerolls for potency inflation

  • Regulation & Compliance

    Exclusive: Does Stiiizy have a diiiversiiion problem?

  • Industry Voices

    Calif. interstate commerce law opens pathway for licensed operators

Related Articles

See More Medical Marijuana Articles
Former TMS CEO joins Beyond Marketing as Medical and Education Director
Sponsored

Former TMS CEO joins Beyond Marketing as Medical and Education Director

The Republican Case for Legalization with Clint Olivier
Medical Marijuana

The Republican Case for Legalization with Clint Olivier

Tilray – Market Development Manager
Medical Marijuana

Tilray – Market Development Manager

Become a member and get access to exclusive content.

Join Now!

Footer

Join WeedWeek Pro

Become A Member Today and Get Access to Exclusive Content. Join here

Follow us

Follow WeedWeek for more content.

  • Instagram
  • LinkedIn
  • Twitter
  • About
  • Privacy Policy
  • Terms & Conditions
  • Contact
  • Advertise

RegStream Media Group © 2025. All Rights Reserved